Family Planning Associates Medical Group INC
Family Planning Associates Medical Group INC was paid $1.66M by Medicaid between Jan 2018 and Sep 2023, across 45 billing codes. Its largest line is S0199, Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs — 18% of everything it billed.
SACRAMENTO, CA 95825
Next to other Ambulatory Family Planning Facility providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,724 | $760K | |
| 2019 | 12,718 | $380K | |
| 2020 | 8,440 | $187K | |
| 2021 | 3,752 | $129K | |
| 2022 | 3,745 | $143K | |
| 2023 | 1,721 | $60K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 18% | 1,710 | 1,301 | $291K |
| J3490 | Unclassified drugs | 11% | 6,025 | 4,744 | $189K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 11% | 411 | 336 | $186K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.1% | 2,436 | 2,215 | $134K |
| 59840 | 6.8% | 1,441 | 672 | $114K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6.1% | 1,183 | 1,052 | $101K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 5.8% | 174 | 144 | $95K |
| 58300 | 4.8% | 912 | 407 | $80K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.0% | 2,627 | 2,414 | $66K |
| S4993 | Contraceptive pills for birth control | 3.5% | 626 | 551 | $59K |
| 11981 | 3.5% | 415 | 357 | $58K | |
| A4267 | Contraceptive supply, condom, male, each | 3.1% | 3,901 | 3,398 | $52K |
33 more codes
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 2.4% | 2,526 | $39K |
| S0191 | Misoprostol, oral, 200 mcg | 2.0% | 1,091 | $34K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.7% | 1,304 | $29K |
| 99203 | Doctor's office visit, new patient (routine) | 1.5% | 144 | $24K |
| S0190 | Mifepristone, oral, 200 mg | 1.0% | 1,075 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,128 | $16K |
| G9920 | Screening performed and negative | <1% | 648 | $15K |
| 99201 | <1% | 357 | $11K | |
| 90651 | <1% | 42 | $7K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 45 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 210 | $6K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 1,068 | $6K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 293 | $4K |
| 11976 | <1% | 131 | $3K | |
| 58301 | <1% | 186 | $3K | |
| 99000 | <1% | 217 | $3K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 84 | $3K |
| 81025 | <1% | 2,861 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 37 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,126 | $715.77 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 30 | $566.55 |
| 01966 | <1% | 34 | $453.94 | |
| 85018 | <1% | 24 | $396.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 47 | $360.44 |
| 87806 | <1% | 399 | $354.09 | |
| 86592 | <1% | 702 | $224.23 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $102.98 |
| 81002 | <1% | 280 | $36.80 | |
| A4649 | Surgical supply; miscellaneous | <1% | 12 | $36.00 |
| 87210 | <1% | 19 | $24.92 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 31 | $0.00 |
| 87481 | 0% | 44 | $0.00 | |
| 87799 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.